These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 626078)

  • 1. Phenobarbital metabolism in adults and in newborn infants.
    Boréus LO; Jalling B; Kållberg N
    Acta Paediatr Scand; 1978 Mar; 67(2):193-200. PubMed ID: 626078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital disposition in the neonate.
    Garrettson LK
    Addict Dis; 1975; 2(1-2):179-85. PubMed ID: 1163361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of phenobarbital in the treatment of seizures in newborns.
    Jalling B
    Acta Paediatr Scand; 1975 May; 64(3):514-24. PubMed ID: 1155069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacology of Phenobarbital in Neonates: Effects, Metabolism and Pharmacokinetics.
    Pacifici GM
    Curr Pediatr Rev; 2016; 12(1):48-54. PubMed ID: 26496779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital--valporic acid interaction.
    Patel IH; Levy RH; Cutler RE
    Clin Pharmacol Ther; 1980 Apr; 27(4):515-21. PubMed ID: 6766833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of phenobarbital glucosidation in the human neonate.
    Bhargava VO; Garrettson LK
    Dev Pharmacol Ther; 1988; 11(1):8-13. PubMed ID: 3383723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of phenobarbital in childhood.
    Heimann G; Gladtke E
    Eur J Clin Pharmacol; 1977 Dec; 12(4):305-10. PubMed ID: 590316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital in newborns with neonatal seizures. A study of plasma levels after intravenous administration.
    Gherpelli JL; Cruz AM; Tsanaclis LM; Costa HP; Garcia TG; Segre CA; Spina-França A
    Brain Dev; 1993; 15(4):258-62. PubMed ID: 8250146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma concentrations of phenobarbital and dosage according to age].
    Alix D; Berthou F; Riche C; Castel Y
    Dev Pharmacol Ther; 1984; 7 Suppl 1():164-70. PubMed ID: 6518958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of phenobarbital following single and repeated doses.
    Viswanathan CT; Booker HE; Welling PG
    J Clin Pharmacol; 1979; 19(5-6):282-9. PubMed ID: 469023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenobarbital concentrations in the cerebrospinal fluid and blood of newborn infants after administration of a single dose].
    Bourin M; Mouzard A; Kergueris MF; Alix D; Riche C; Le Normand Y; Larousse C
    Therapie; 1983; 38(1):47-51. PubMed ID: 6867999
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma concentrations of phenobarbital in mother and child after combined prenatal and postnatal administration for prophylaxis of hyperbilirubinemia.
    Boréus LO; Jalling B; Wallin A
    J Pediatr; 1978 Oct; 93(4):695-8. PubMed ID: 702253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
    Whyte MP; Dekaban AS
    Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of injectable phenobarbital in the premature infant. Study of a new lyophilized form].
    Kossmann JC; Ribon B; Claris O; Brazier JL; Salle B
    Arch Fr Pediatr; 1985 Apr; 42(4):317-20. PubMed ID: 4004495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of urine pH modification on pharmacokinetics of phenobarbital in healthy dogs.
    Fukunaga K; Saito M; Muto M; Mishima K; Fujiwara M; Orito K
    J Vet Pharmacol Ther; 2008 Oct; 31(5):431-6. PubMed ID: 19000262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase.
    Elvin AT; Lalka D; Stoeckel K; du Souich P; Axelson JE; Golden LH; McLean AJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):652-8. PubMed ID: 6777107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.